These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9008662

  • 41. Effects of dehydroepiandrosterone replacement in elderly men on event-related potentials, memory, and well-being.
    Wolf OT, Naumann E, Hellhammer DH, Kirschbaum C.
    J Gerontol A Biol Sci Med Sci; 1998 Sep; 53(5):M385-90. PubMed ID: 9754145
    [Abstract] [Full Text] [Related]

  • 42. [Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy].
    Römmler A.
    Gynakol Geburtshilfliche Rundsch; 2003 Apr; 43(2):79-90. PubMed ID: 12649580
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects.
    Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Gross DJ, Friedman G.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2911-4. PubMed ID: 9284718
    [Abstract] [Full Text] [Related]

  • 45. Dehydroepiandrosterone, ageing and immune activation.
    Ledochowski M, Murr C, Jäger M, Fuchs D.
    Exp Gerontol; 2001 Nov; 36(10):1739-47. PubMed ID: 11672993
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA.
    J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
    [Abstract] [Full Text] [Related]

  • 51. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.
    Acacio BD, Stanczyk FZ, Mullin P, Saadat P, Jafarian N, Sokol RZ.
    Fertil Steril; 2004 Mar; 81(3):595-604. PubMed ID: 15037408
    [Abstract] [Full Text] [Related]

  • 52. Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.
    Legrain S, Girard L.
    Drugs Aging; 2003 Mar; 20(13):949-67. PubMed ID: 14561100
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.